The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome

Anesthesia and Analgesia

Volumn 111, Issue 3, 2010, Pages 638-646

  Schwoerer, Alexander P ^a   Kebernik, Julia ^a   Ehmke, Heimo ^a   Friederich, Patrick ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM CHANNEL L TYPE; CHROMANOL 293B; DROPERIDOL; SODIUM CALCIUM EXCHANGE PROTEIN; 6 CYANO 4 (N ETHYLSULFONYL N METHYLAMINO) 3 HYDROXY 2,2 DIMETHYLCHROMANE; 6-CYANO-4-(N-ETHYLSULFONYL-N-METHYLAMINO)-3-HYDROXY-2,2-DIMETHYLCHROMANE; ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; CARDIOPLEGIC AGENT; CHROMAN DERIVATIVE; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; PYRIDINE DERIVATIVE; SULFONAMIDE;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TARGETING; GUINEA PIG; HEART DEPOLARIZATION; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; LONG QT SYNDROME; MATHEMATICAL MODEL; NONHUMAN; PERIOPERATIVE PERIOD; POTASSIUM CURRENT; PRIORITY JOURNAL; ACTION POTENTIAL; ADULT; ANIMAL; CELL SEPARATION; CHEMICALLY INDUCED DISORDER; COMPUTER SIMULATION; DRUG EFFECT; HUMAN; PATCH CLAMP; PATHOLOGY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ACTION POTENTIALS; ADULT; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIEMETICS; CARDIOPLEGIC SOLUTIONS; CELL SEPARATION; CHROMANS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DROPERIDOL; GUINEA PIGS; HUMANS; LONG QT SYNDROME; MODELS, STATISTICAL; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; PYRIDINES; SULFONAMIDES;

EID: 77956415988     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181e41996     Document Type: Article

References (43)

1. Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975;89:378-90
2. Zipes DP. The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991;84:1414-9
3. Morita H, Wu J, Zipes DP. The QT syndromes: long and short. Lancet 2008;372:750-63
4. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996;384:80-3
5. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996; 384:78-80
6. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995;81:299-307
7. Odening KE, Hyder O, Chaves L, Schofield L, Brunner M, Kirk M, Zehender M, Peng X, Koren G. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. Am J Physiol Heart Circ Physiol 2008;295: H2264-72
8. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006;440:463-9
9. Kang J, Reynolds WP, Chen XL, Ji J, Wang H, Rampe DE. Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. Anesthesiology 2006;104:1015-22
10. + channel structure-activity relationships and mechanisms of drug-induced QT prolongation. Annu Rev Pharmacol Toxicol 2003;43:441-61
11. Booker PD, Whyte SD, Ladusans EJ. Long QT syndrome and anaesthesia. Br J Anaesth 2003;90:349-66
12. Kies SJ, Pabelick CM, Hurley HA, White RD, Ackerman MJ. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005;102:204-10
13. Villain E, Denjoy I, Lupoglazoff JM, Guicheney P, Hainque B, Lucet V, Bonnet D. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 2004;25:1405-11
14. Moss AJ, Robinson JL, Gessman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999;84:876-9
15. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotypephenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103: 89-95
16. Siebrands CC, Binder S, Eckhoff U, Schmitt N, Friederich P. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current. Anesthesiology 2006;105:511-20
17. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramer MR, Watcha M. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71
18. Scuderi PE. Droperidol: many questions, few answers. Anesthesiology 2003;98:289-90
19. Schwoerer AP, Bluetner C, Brandt S, Binder S, Siebrands CC, Ehmke H, Friederich P. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization. Anesthesiology 2007;106:967-76
20. Drolet B, Zhang S, Deschenes D, Rail J, Nadeau S, Zhou Z, January CT, Turgeon J. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999;10:1597-604 (Pubitemid 30020497)
21. Mironneau C, Mironneau J, Grosset A. Action of droperidol on the ionic currents and the contraction of the sino-auricular fiber of frogs: study of its anti-arrhythmic properties [in French]. J Physiol 1975;70:27-39
22. Adamantidis MM, Kerram P, Caron JF, Dupuis BA. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers. J Pharmacol Exp Ther 1993;266:884-93
23. 2+, myofilament Ca2± sensitivity, and contraction in rat ventricular myocytes. Anesthesiology 2005;102:1165-73
24. Kern R, Einwachter HM, Haas HG, Lack EG. Cardiac membrane currents as affected by an neuroleptic agent: droperidol. Pflugers Arch 1971;325:262-78
25. Hauswirth O. Effects of droperidol on sheep Purkinje fibers. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1968;261:133-42
26. Carmeliet E, Xhonneux R, Van Glabbeek A, Reneman R. Electrophysiological effects of droperidol in different cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol 1976; 293:57-66
27. Weissenburger J, Funck-Brentano C, Jaillon P, Charbit B. Droperidol and ondansetron in vitro electrophysiological drug interaction study. Fundam Clin Pharmacol 2009;23:719-26
28. Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003;96:1377-9
29. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTcinterval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-52
30. Zhang Y, Luo Z, White PF. A model for evaluating droperidol's effect on the median QTc interval. Anesth Analg 2004;98:1330-5
31. Guy JM, Andre-Fouet X, Porte J, Bertrand M, Lamaud M, Verneyre H. Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol [in French]. Ann Cardiol Angeiol 1991;40:541-5
32. White PF, Song D, Abrao J, Klein KW, Navarette B. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study. Anesthesiology 2005;102:1101-5
33. Ludwin DB, Shafer SL. Con: the black box warning on droperidol should not be removed (but should be clarified!). Anesth Analg 2008;106:1418-20
34. Habib AS, Gan TJ. Pro: the Food and Drug Administration black box warning on droperidol is not justified. Anesth Analg 2008;106:1414-7
35. Habib AS, Gan TJ. Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel? Anesth Analg 2008;106:1343-5
36. Katz RI. Some points regarding anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005;103: 1315-6
37. Luo CH, Rudy Y. A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res 1991;68:1501-26
38. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K± current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215
39. Bosch RF, Gaspo R, Busch AE, Lang HJ, Li GR, Nattel S. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K± current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res 1998;38:441-50
40. Yang Z, Shi G, Li C, Wang H, Liu K, Liu Y. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J Cardiovasc Electrophysiol 2004;15:815-20
41. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PK. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action. Circ Res 1991;68:77-84
42. Marty J, Nitenberg A, Blanchet F, Laffay N, Mazze RI, Desmonts JM. Effects of droperidol on left ventricular performance in humans. Anesthesiology 1982;57:22-5
43. Kanters JK, Fanoe S, Larsen LA, Bloch Thomsen PE, Toft E, Christiansen M. T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm 2004;1:285-92